Allergen-specific immunotherapy with recombinant grass pollen allergens

A recombinant allergen vaccine can be a effective and safe treatment to ameliorate symptoms of allergic rhinitis. The clinical benefit is associated with modification of the specific immune response with promotion of IgG4 and reduction of IgE antibodies consistent with the induction of IL-10-producing regulatory T cells.